Stelmes Jean-Jacques, Gregoire Vincent, Poorten Vincent Vander, Golusiñski Wojciech, Szewczyk Mateusz, Jones Terry, Ansarin Mohssen, Broglie Martina A, Giger Roland, Klussmann Jens Peter, Evans Mererid, Bourhis Jean, Leemans C René, Spriano Giuseppe, Dietz Andreas, Hunter Keith, Zimmermann Frank, Tinhofer Ingeborg, Patterson Joanne M, Quaglini Silvana, Govaerts Anne-Sophie, Fortpied Catherine, Simon Christian
Department of Radiation Oncology, University Hospital Zurich (USZ), Zurich, Switzerland.
Department of Radiation Oncology, Centre Léon Bérard, Lyon, France.
Front Oncol. 2019 Oct 22;9:999. doi: 10.3389/fonc.2019.00999. eCollection 2019.
Dysphagia represents one of the most serious adverse events after curative-intent treatments with a tremendous impact on quality of life in patients with head and neck cancers. Novel surgical and radiation therapy techniques have been developed to better preserve swallowing function, while not negatively influencing local control and/or overall survival. This review focuses on the current literature of swallowing outcomes after curative treatment strategies. Available results from recent studies relevant to this topic are presented, demonstrating the potential role of new treatment modalities for early- and intermediate-stage oropharyngeal cancers. Based on this, we present the rationale and design of the currently active EORTC 1420 "Best of" trial, and highlight the potential of this study to help prioritizing either surgery- or radiation-based treatment modalities for the treatment of oropharyngeal cancer in the future.
吞咽困难是根治性治疗后最严重的不良事件之一,对头颈部癌症患者的生活质量有巨大影响。已开发出新的手术和放射治疗技术,以更好地保留吞咽功能,同时不负面影响局部控制和/或总生存期。本综述重点关注根治性治疗策略后吞咽结果的当前文献。介绍了近期与该主题相关研究的可用结果,证明了新治疗模式对早期和中期口咽癌的潜在作用。基于此,我们介绍了目前正在进行的欧洲癌症研究与治疗组织(EORTC)1420“最佳选择”试验的基本原理和设计,并强调了该研究在未来帮助确定口咽癌基于手术或放疗的治疗模式优先级方面的潜力。